The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
Abstract
PURPOSE: More than 90% of Ewing's sarcomas (ES) contain a fusion of the EWS and FLI1 genes, due to the t(11;22)(q24;q12) translocation. At the molecular level, the EWS-FLI1 rearrangements show great diversity. Specifically, many different combinations of exons from EWS and FLI1 encode in-frame fusion transcripts and result in differences in the length and composition of the chimeric protein, which functions as an oncogenic aberrant transcription factor. In the most common fusion type (type 1), EWS exon 7 is linked in frame with exon 6 of FLI1. As the fundamental pathogenetic lesion in ES, the molecular heterogeneity of these fusion transcripts may have functional and clinical significance. PATIENTS AND METHODS: We performed a clinical and pathologic analysis of 112 patients with ES in which EWS-FLI1 fusion transcripts were identified by reverse-transcriptase polymerase chain reaction (RT-PCR). Adequate treatment and follow-up data were available in 99 patients treated with curative intent. Median follow-up in these 99 patients was 26 months (range, 1 to 140 months). Univariate and multivariate survival analyses were performed that included other prognostic factors, such as age, tumor location, size, and stage. RESULTS: Among the 99 patients suitable for survival analysis, the tumors in 64 patients contained the type 1 fusion and in 35 patients contained less common fusion types. Stage at presentation was localized in 74 patients and metastatic in 25. Metastases (relative risk [RR] = 2.6; P = .008), and type 1 EWS-FLI1 fusion (RR = 0.37; P = .014) were, respectively, independent negative and positive prognostic factors for overall survival by multivariate analysis. Among 74 patients with localized tumors, the type 1 EWS-FLI1 fusion was also a significant positive predictor of overall survival (RR = 0.32; P = .034) by multivariate analysis. CONCLUSION: EWS-FLI1 fusion type appears to be prognostically relevant in ES, independent of tumor site, stage, and size. Further studies are needed to clarify the biologic basis of this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Self-citationMelo, J. (1996) · Blood · doi:10.1182/blood.v88.7.2375.bloodjournal8872375 · Cited by 723
SYT–SSX Gene Fusion as a Determinant of Morphology and Prognosis in Synovial Sarcoma
Kawai, A., Woodruff, J., Healey, J. H., Brennan, M. F., Antonescu, C. R., & Ladanyi, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380303 · Cited by 663
Self-citationMay, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., & Turc-Carel, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06137.x · Cited by 539
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
A new member of the ETS family fused to EWS in Ewing tumors
Peter, M., Couturier, J., Pacquement, H., Michon, J., Thomas, G., Magdelenat, H., & Delattre, O. (1997) · Oncogene · doi:10.1038/sj.onc.1200933 · Cited by 397
Bailly, R.-A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., & Ghysdael, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3230-3241.1994 · Cited by 297
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Kaneko, Y., Yoshida, K., Handa, M., Toyoda, Y., Nishihira, H., Tanaka, Y., Sasaki, Y., Ishida, S., Higashino, F., & Fujinaga, K. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<115::aid-gcc6>3.0.co;2-6 · Cited by 239
Molecular Assays for Chromosomal Translocations in the Diagnosis of Pediatric Soft Tissue Sarcomas
Barr, F. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310051029 · Cited by 225
Self-citationCommon and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly, K. M., Womer, R. B., Sorensen, P. H., Xiong, Q. B., & Barr, F. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1831 · Cited by 203
Self-citationUrano, F., Umezawa, A., Hong, W., Kikuchi, H., & Hata, J.-I. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0281 · Cited by 175
EWS/Fli-1 chimeric protein is a transcriptional activator.
Ohno, T., Rao, V. N., & Reddy, E. S. (1993) · PubMed · Cited by 167
Kushner, B. H., Meyers, P. A., Gerald, W. L., Healey, J. H., La Quaglia, M. P., Boland, P., Wollner, N., Casper, E. S., Aledo, A., & Heller, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2796 · Cited by 163
Self-citationGiovannini, M., Biegel, J. A., Serra, M., Wang, J. Y., Wei, Y. H., Nycum, L., Emanuel, B. S., & Evans, G. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117360 · Cited by 162
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar, H., Aryee, D. N. T., Jug, G., Henöckl, C., SCHEMPER, M., Delattre, O., Thomas, G. D., & Gadner, H. (1996) · PubMed · Cited by 147
de Alava, E., Ladanyi, M., Rosaí, J., & Gerald, W. L. (1995) · Europe PMC (PubMed Central) · Cited by 136
Self-citationLoss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida, M., Ohno, T., Fujimura, Y., Rao, V. N., & Reddy, E. S. P. (1995) · PubMed · Cited by 136
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
Plougastel-Douglas, B., Zucman‐Rossi, J., Peter, M., Thomas, G. D., & Delattre, O. (1993) · Genomics · doi:10.1016/s0888-7543(05)80363-5 · Cited by 108
Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
Rao, V. N., Ohno, T., Dd, P., Bhattacharya, G., & Reddy, E. S. (1993) · PubMed · Cited by 88
Structure and expression of human Fli-1 gene.
Prasad, D. D. K., Rao, V. N., & Reddy, E. S. P. (1992) · PubMed · Cited by 59
SRE elements are binding sites for the fusion protein EWS-FLI-1
Magnaghi-Jaulin, L. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1052 · Cited by 47
Comparison of Soft Tissue Ewing's Sarcoma and Peripheral Neuroectodermal Tumor
Siebenrock, K. A., Nascimento, A. G., & Rock, M. G. (1996) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199608000-00036 · Cited by 39
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationSorensen, P. H. B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., & Barr, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.137 · Cited by 742
Self-citationEwing Sarcoma: Current Management and Future Approaches Through Collaboration
Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 722
Self-citationBalamuth, N. J., & Womer, R. B. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70286-4 · Cited by 686
Self-citationCommon Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., & Crist, W. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410507 · Cited by 657
Metadata
- Authors
- de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., Pardo-Mindan, F. J., Ginsberg, J., Womer, R., Lawlor, E. R., Wunder, J., Andrulis, I., Sorensen, P. H., Barr, F. G., & Ladanyi, M.
- Venue
- Journal of Clinical Oncology
- Published
- 1998-04
- Volume
- 16
- Issue
- 4
- Pages
- 1248-1255
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1924823925
- Cited by
- 524
- References
- 28
- FWCI
- 32.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.